DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.8% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $435.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/16/2026ACC: 0001310204-26-000029
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$435.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$145.29
Trade value
$435.87K
% of position
1.8%
9/15/2026
167.10K→164.10K
Total
Net shares
−3K
Net value
-$435.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | S · Sale | −3K | $145.29 | $435.87K | 1.8% | 167.10K | 164.10K |
| Total | −3K | -$435.87K | ||||||
Derivative Transactions0
No derivative transactions reported